leisure time -WSS

leisure time

author：hotspot 2025-09-28 23:29:54 - browse：1772

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Kristina Burow of ARCH Venture Partners shares her next big bets STAT

explore

WSS

Flu vaccine offering decent levels of protection this winter, new data show

Congress gives doctors Medicare pay bump

RSV vaccines may be linked to small increased risk of developing GBS

Flu vaccine offering decent levels of protection this winter, new data show

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

The perfect storm of weather conditions that led to the devastating wildfires in Maui

knowledge

leisure time

focus

Malaria cases in Florida and Texas: Here’s what you need to know

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Hepatitis C has a cure — but many Americans still lack access to it

International team creates first chimeric human

ChatGPT in medicine: STAT answers readers' burning questions

Biotech companies concerned about China biosecurity crackdown

Anesthesiologist group: stop taking Ozempic before surgery

Why getting cancer drugs just got harder for rural patients

Hollywood unions extend contract negotiations for actors

TB outbreak tied to bone grafts underscores testing shortcomings

knowledge

AstraZeneca loses challenge to Medicare drug price negotiation

Obesity now affects over 1 billion people worldwide, study finds

How to address the problem of discarded donor organs

FDA does about

Obesity now affects over 1 billion people worldwide, study finds

Kim Kardashian sparks debate on benefits of full

explore

Wikipedia

leisure time

explore